Elocon and Cellulitis - a phase IV clinical study of FDA data

Summary:

Cellulitis is reported as a side effect among people who take Elocon (mometasone furoate), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Indapamide, and have Dermatitis atopic.

The phase IV clinical study analyzes which people have Cellulitis when taking Elocon. It is created by eHealthMe based on reports of 1,989 people who have side effects when taking Elocon from the FDA, and is updated regularly.

What is Elocon?

Elocon has active ingredients of mometasone furoate. It is often used in eczema. eHealthMe is studying from 2,019 Elocon users. Check the latest studies of Elocon.

What is Cellulitis?

Cellulitis (infection under the skin) is found to be associated with 2,110 drugs and 2,337 conditions by eHealthMe. Check the latest studies of Cellulitis.

On Jun, 18, 2026

1,989 people reported to have side effects when taking Elocon.
Among them, 26 people (1.31%) have Cellulitis.

Among these 26 people:

How long have people been on Elocon when they have Cellulitis? *

What is the gender of people who have Cellulitis when taking Elocon? *

female: 61.9 %
male: 38.1 %

What is the age of people who have Cellulitis when taking Elocon? *

What are other drugs people take besides Elocon? *

What are other side effects people have besides Cellulitis? *

Rashes (redness): 8 people, 30.77%
Skin Necrosis (skin damage): 5 people, 19.23%
Herpes Virus Infection: 4 people, 15.38%
Staphylococcal Infection (an infection with staphylococcus bacteria): 4 people, 15.38%
Rash Erythematous (redness of the skin): 4 people, 15.38%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 4 people, 15.38%
Serratia Infection (bacterial infection): 4 people, 15.38%
Candidiasis (candidiasis or thrush is a fungal infection): 4 people, 15.38%
Dermatitis Infected (inflammation of the skin due to infection): 4 people, 15.38%
Tumor: 4 people, 15.38%

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 6 people, 23.08%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 7.69%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 7.69%
Breast Cancer: 2 people, 7.69%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 3.85%
Post Polio Syndrome: 1 person, 3.85%
Lichen Sclerosus (a skin disorder that causes the skin to become thin, whitened, wrinkled, and can cause itching and pain): 1 person, 3.85%
Itching: 1 person, 3.85%
Immunodeficiency Disorders: 1 person, 3.85%
High Blood Cholesterol: 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Elocon and have Cellulitis?

- Check whether Cellulitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Elocon:

Elocon (2,019 reports)

Cellulitis treatments and more:

Cellulitis (75,290 reports)

Browse all side effects of Elocon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cellulitis:

Cellulitis (2,110 drugs)

Browse all the conditions that are associated with Cellulitis:

Cellulitis (2,337 conditions)

Related publications that referenced our studies

Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on mometasone furoate (the active ingredients of Elocon) and Elocon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.